The Pharmacological Therapy segment is the leading management type category of the Diabetes-Related PAD Management Market, with a 40.7% share in 2026. A share of 40.1% by end user belongs to Hospitals, while the disease stage segment is headed by Asymptomatic PAD at 36.0%.